# Yamaguchi Syndrome: A Case of Apical Hypertrophic Cardiomyopathy in a Patient From West Africa

**Authors:** Andrew S Dzebu, David Awini

PMC · DOI: 10.7759/cureus.103543 · Cureus · 2026-02-13

## TL;DR

A 61-year-old man from West Africa was diagnosed with a rare heart condition called Yamaguchi syndrome, which is typically more common in Asian populations.

## Contribution

This case report highlights the rare occurrence of Yamaguchi syndrome in a West African individual.

## Key findings

- The patient showed apical left ventricular hypertrophy consistent with Yamaguchi syndrome.
- Treatment with carvedilol led to resolution of chest pain and improved quality of life.
- The patient had a low risk of sudden cardiac death and normal coronary arteries.

## Abstract

Hypertrophic cardiomyopathy is the most common genetic cardiomyopathy. The apical variant, also known as Yamaguchi syndrome, is a rare condition that is reportedly more prevalent in Asian populations. It is characterized by hypertrophy predominantly limited to the left ventricular apex, with a classic "ace of spades" shaped left ventricular cavity. We present a 61-year-old male of West African descent with a chest pain syndrome and deep inverted precordial T-waves on 12-lead electrocardiography. Two-dimensional echocardiography demonstrated focal left ventricular hypertrophy limited to the apex, and speckle-tracking imaging showed reduced apical strain, findings consistent with apical hypertrophic cardiomyopathy (HCM). Risk assessment for sudden cardiac death was low. A previous invasive coronary artery angiography reported normal epicardial coronary arteries. The patient was started on carvedilol 6.25 mg orally twice daily, with resolution of the chest pain and, so far, a generally optimal quality of life after four months of follow-up.

## Linked entities

- **Chemicals:** carvedilol (PubChem CID 2585)
- **Diseases:** hypertrophic cardiomyopathy (MONDO:0005045)

## Full-text entities

- **Diseases:** Apical Hypertrophic Cardiomyopathy (MESH:D000092183), hypertrophy (MESH:D006984), cardiomyopathy (MESH:D009202), left ventricular hypertrophy (MESH:D017379), chest pain (MESH:D002637), sudden cardiac death (MESH:D016757), HCM (MESH:D002312), Yamaguchi Syndrome (MESH:C537096)
- **Chemicals:** carvedilol (MESH:D000077261)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12989248/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12989248/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC12989248/full.md

---
Source: https://tomesphere.com/paper/PMC12989248